Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

NCT00125606 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class

Stopped insufficient patient recruitement

Conditions

Interventions

Sponsor

University Hospital Muenster

Collaborators